This is based upon our report of a significant association of the mitochondrial J and K haplogroups with Parkinson Disease (PD), especially their common polymorphism A10398G (p equals approximately 0.0001), which causes a Thr--> Ala change in the complex I subunit ND3 (van der Walt et al. 2003). Relative to the most common haplogroup H, we found that the J and K haplogroups and the10398G allele provided a protective effect against developing PD. This finding supports a growing body of work that implicates complex I of the mitochondria with direct involvement in PD risk Our hypothesis is that the J and K haplogroups and/or the 10398 SNP provide a biological advantage over other haplogroups that lessens an individuals' susceptibility to develop PD. Using the well-established technique of cybrids, this project will seek to identify those functional changes in mitochondria and complex I associated with these haplogroups and the 10398 polymorphism. This should also provide insight into the role of complex I in PD. To do this, we have brought together the expertise of three laboratories: 1) the clinical, genetics and expression analyses of our own Udall center, 2) the cybrid and disease-specific mitochondrial expertise of Dr. Jim Bennett's laboratory in the Udall Center at the University of Virginia, and 3) the mitochondrial structural expertise of Dr. Rod Capaldi's laboratory at the University of Oregon.
Our specific aims are as follows: 1) Creation of cybrids from individuals with J, K and H mitochondrial haplotypes. 2) Gene expression changes of cybrids carrying different mitochondrial haplogroups. We will initially grow cybrids of J, K and H haplogroups with chronic rotenone and protected by 17beta estradiol to attempt to identify response differences 3) Identifying possible """"""""functional"""""""" differences in the amounts, the functioning and the sensitivity to oxidative stress of mitochondria and complex I in the different cybrid lines, isolating functional complex I using monoclonal antibodies 4) genotypic stratification of the J and K haplotype and 5) Association analysis for PD susceptibility with nuclear encoded mitochondrial genes.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZNS1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
United States
Zip Code
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Nuytemans, Karen; Maldonado, Lizmarie; Ali, Aleena et al. (2016) Overlap between Parkinson disease and Alzheimer disease in ABCA7 functional variants. Neurol Genet 2:e44
Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717
Mez, Jesse; Mukherjee, Shubhabrata; Thornton, Timothy et al. (2016) The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. Neurobiol Aging 41:115-121
Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150
Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17
Ebbert, Mark T W; Boehme, Kevin L; Wadsworth, Mark E et al. (2016) Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk. Alzheimers Dement 12:121-129

Showing the most recent 10 out of 114 publications